News

NEWS
Press-Release
November 30, 2021
InSysBio to launch its new website

The new website represents InSysBio’s diverse expertise and corporate philosophy

InSysBio announces the launch of its new website. The aim of redesign was to fully represent all InSysBio’s diversified experience and to reflect the company’s current trend. The new website is more structured, user-friendly and provides more opportunities for feedback.
LEARN MORE
NEWS
Education
October 12, 2021
InSysBio to start its annual course at Lomonosov Moscow State University
This year InSysBio CEO Oleg Demin and Head of IRT team Veronika Musatova are giving the course "Mathematical modeling in systems biology and biomedicine" at the Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University.
LEARN MORE
NEWS
Education
October 6, 2021
InSysBio to start the lectures at Lomonosov Moscow State University
InSysBio expert modeler Tatiana Karelina will give the lectures on QSP modeling for the Master's degree students at the Faculty of Physics, Lomonosov Moscow State University.
LEARN MORE
NEWS
Press-Release
August 11, 2021
InSysBio to launch its OpenSource HetaSimulator project
The new platform is a part of Heta-based QSP modeling infrastructure [Moscow – 11.08.2021] InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, now presents HetaSimulator. It is a part of Heta project that embraces three components. HetaSimulator is an OpenSource simulation and parameters estimation platform for the Heta modeling language.
LEARN MORE
NEWS
Press-Release
July 22, 2021
InSysBio to present Immune Response Template v. 3.5.0
Now IRT gets significant update and a portion of new data [Moscow – 22.07.2021] InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, launches Immune Response Template (IRT) version 3.5.0.
LEARN MORE
NEWS
Education
June 2, 2021
InSysBio's student to defend diploma thesis
Elena Vasileva, student of Lomonosov Moscow State University (MSU) has developed her diploma thesis in InSysBio and successfully passed its defense. Her diploma thesis entitled “Optimization of anti-CD47 therapeutic agent dosage using PK/PD modeling” was supervised by Oleg Demin Jr, Head of Oncology and Immuno-Oncology at InSysBio.
LEARN MORE
May 2022
MoTuWeThFrSaSu
      
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1. 24 May 2022 13:04 InSysBio to establish a new legal entity in Cyprus InSysBio announces the creation of a new legal entity INSYSBIO CY Ltd. InSysBio continues the development of its QSP services and QSP tools infrastructure and contributing its experience to global research. Oleg Demin, CEO of InSysBio, comments on the significance and goals of this step.
25
26
27
28
29
30
31
     
Upcoming Events
Tags